Promoting patient and site centricity in neurodegenerative disease clinical trials

Operationalizing complex, rare neuromuscular clinical trials

Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support.

Patient-centric practices for AD

Sharing our best patient-centric practices from extensive experience in Alzheimer’s Disease.

Cardio-metabolic rare diseases: strategic insights for country and site distribution

Understand key considerations for study design, country and site selection.

Cardiovascular outcome trials: strategic insights for country and site distribution

Get strategic insights for country and site distribution.

Cardiovascular

Beating cardiovascular disease requires a strategic, scientific approach. From tracking changing disease patterns in an aging population to developing cutting edge approaches to disease management, Fortrea has solutions.

Rare Diseases

Fortrea specializes in rare diseases research and orphan drug development. Partner with us for innovative solutions in rare disease treatments.

Pediatrics

From design to execution, we understand the inherent challenges of pediatric studies and will help you navigate the best path ahead.

Oncology Cell and Gene Therapies

Harness our expertise in oncology cell and gene therapies (CGTs) to accelerate your cancer treatment breakthroughs. From early-phase trials to market access, we deliver tailored solutions that bring life-changing therapies to patients faster.

Gene Therapies

With a track record of success across multiple gene therapy modalities, we combine scientific excellence, deep regulatory insights and operational agility to accelerate your program from concept to approval, ensuring your therapy reaches the patients who need it most.